Please use this identifier to cite or link to this item: http://hdl.handle.net/10637/14028

Potential neuroprotective role of sugammadex : a clinical study on cognitive function assessment in an enhanced recovery after cardiac surgery approach and an experimental study


Thumbnail

See/Open:
 Potential_Muedra_FICN_2022.pdf
2,96 MB
Adobe PDF
Title: Potential neuroprotective role of sugammadex : a clinical study on cognitive function assessment in an enhanced recovery after cardiac surgery approach and an experimental study
Authors : Muedra Navarro, Vicente
Rodilla Alamà, Vicente
Llansola, Marta
Agustí Feliu, Ana
Pla, Clara
Cantó Catalá, Antolín
Hernández Rabaza, Vicente
Keywords: Sugammadex - Therapeutic use.Microglia.Microglía.Memory disorders.Corazón - Cirugía.Heart - Surgery.Memoria - Trastornos.Sugammadex - Uso terapéutico.
Publisher: Frontiers Media
Citation: Muedra, V., Rodilla, V., Llansola, M., Agustí, A., Pla, C., Canto, A., & Hernández-Rabaza, V. (2022). Potential neuroprotective role of Sugammadex: a clinical study on cognitive function assessment in an enhanced recovery after cardiac surgery approach and an experimental study. Frontiers in Cellular Neuroscience, vol. 16, art. 789796 (21 feb.). DOI: https://doi.org/10.3389/fncel.2022.789796
Abstract: Background: Postoperative cognitive dysfunction affects the quality of recovery, particularly affecting the elderly, and poses a burden on the health system. We hypothesize that the use of sugammadex (SG) could optimize the quality of postoperative cognitive function and overall recovery through a neuroprotective effect. Methods: A pilot observational study on patients undergoing cardiac surgery with enhanced recovery after cardiac surgery (ERACS) approach, was designed to compare SG-treated (n = 14) vs. neostigmine (NG)-treated (n = 7) patients. The Postoperative Quality Recovery Scale (PQRS) was used at different times to evaluate cognitive function and overall recovery of the patients. An online survey among anesthesiologists on SG use was also performed. Additionally, an animal model study was designed to explore the effects of SG on the hippocampus. Results: Sugammadex (SG) was associated with favorable postoperative recovery in cognitive domains particularly 30 days after surgery in patients undergoing aortic valve replacement by cardiopulmonary bypass and the ERACS approach; however, it failed to demonstrate a short-term decrease in length of intensive care unit (ICU) and hospital stay. The survey information indicated a positive appreciation of SG recovery properties. SG reverts postoperative memory deficit and induces the expression of anti-inflammatory microglial markers. Conclusion: The results show a postoperative cognitive improvement by SG treatment in patients undergoing aortic valve replacement procedure by the ERACS approach. Additionally, experimental data from an animal model of mild surgery confirm the cognitive effect of SG and suggest a potential effect over glia cells as an underlying mechanism.
Description: Este artículo se encuentra disponible en la página web de la revista en la siguiente URL: https://www.frontiersin.org/articles/10.3389/fncel.2022.789796/full
URI: http://hdl.handle.net/10637/14028
Rights : http://creativecommons.org/licenses/by/4.0/deed.es
ISSN: 1662-5102 (Electrónico)
Issue Date: 21-Feb-2022
Center : Universidad Cardenal Herrera-CEU
Appears in Collections:Dpto. Ciencias Biomédicas





Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.